Structure |
Chemical Name |
CAS |
MF |
![Rivaroxaban iMpurity A](/CAS/20180906/GIF/931204-39-6.gif) |
Rivaroxaban iMpurity A |
931204-39-6 |
C19H20ClN3O6S |
![R-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo- Methyl ester](/CAS/20150408/GIF/1268719-66-9.gif) |
R-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo- Methyl ester |
1268719-66-9 |
C19H22FN3O4 |
![Ticagrelor Sulfone](/CAS/20150408/GIF/274693-39-9.gif) |
Ticagrelor Sulfone |
274693-39-9 |
C23H28F2N6O6S |
![2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol](/CAS/20150408/GIF/CB02668497.gif) |
2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
1858267-99-8 |
C17H26N6O4S |
![LevosiMendan iMpurity](/) |
LevosiMendan iMpurity |
139052-02-1 |
|
![rac Cinacalcet HCl](/CAS/20211123/GIF/1025064-33-8.gif) |
rac Cinacalcet HCl |
1025064-33-8 |
C22H22F3N |
![AztreonaM IMpurity E](/) |
AztreonaM IMpurity E |
|
|
![Dasatinib IMpurity 1](/) |
Dasatinib IMpurity 1 |
|
|
![Deferasirox IMpurity 1](/) |
Deferasirox IMpurity 1 |
|
|
![Doxycycline Hyclate IMpurity F](/CAS/20180808/GIF/122861-53-4.gif) |
Doxycycline Hyclate IMpurity F |
122861-53-4 |
C23H25NO8 |
![IpratropiuM BroMide IMpurity E](/CAS/20150408/GIF/CB02674528.gif) |
IpratropiuM BroMide IMpurity E |
183626-76-8 |
C19H27NO3 |
![P-トルエンスルホン酸2,6-ジアミノ-4-ピリミジニル3-オキシド](/CAS/GIF/75105-16-7.gif) |
P-トルエンスルホン酸2,6-ジアミノ-4-ピリミジニル3-オキシド |
75105-16-7 |
C11H12N4O4S |
![Ribavirin IMp. D (EP)](/) |
Ribavirin IMp. D (EP) |
|
|
![SalMeterol IMpurity C](/CAS/20150408/GIF/CB02675646.gif) |
SalMeterol IMpurity C |
|
C25H37NO4 |
![SulbactaM IMpurity F](/) |
SulbactaM IMpurity F |
|
|
![N-(4-(2-Methyl-1,4,5,6-tetrahydrobenzo[b]iMidazo[4,5-d]azepine-1-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide](/CAS/20150408/GIF/CB02681126.gif) |
N-(4-(2-Methyl-1,4,5,6-tetrahydrobenzo[b]iMidazo[4,5-d]azepine-1-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide |
|
C32H26N4O2 |
![Epalrestat iMpurity](/CAS/20210111/GIF/109801-00-5.gif) |
Epalrestat iMpurity |
109801-00-5 |
C13H18O |
![5-Oxo Pitavastatin](/CAS/GIF/222306-15-2.gif) |
5-Oxo Pitavastatin |
222306-15-2 |
C25H22FNO4 |
![(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one](/CAS/20150408/GIF/1312077-05-6.gif) |
(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one |
1312077-05-6 |
C12H11NO |
![2-Hydroxy Cephalexin](/CAS/GIF/215172-75-1.gif) |
2-Hydroxy Cephalexin |
215172-75-1 |
C16H17N3O5S |
![3-(9H-Carbazol-4-yloxy)-1,2-propanediol](/CAS/20150408/GIF/123119-89-1.gif) |
3-(9H-Carbazol-4-yloxy)-1,2-propanediol |
123119-89-1 |
C15H15NO3 |
![4-(2-Methylpropoxy)-1,3-benzenedicarbothioaMide](/CAS/20150408/GIF/1330632-46-6.gif) |
4-(2-Methylpropoxy)-1,3-benzenedicarbothioaMide |
1330632-46-6 |
C12H16N2OS2 |
![9-MethoxyMethyl Guanine](/CAS/GIF/1202645-50-8.gif) |
9-MethoxyMethyl Guanine |
1202645-50-8 |
C7H9N5O2 |
![ClindaMycin 3-PalMitate](/CAS/20211123/GIF/68225-59-2.gif) |
ClindaMycin 3-PalMitate |
68225-59-2 |
C34H63ClN2O6S |
![α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol](/CAS/GIF/333749-57-8.gif) |
α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol |
333749-57-8 |
C24H34N2O6 |
![Ticagrelor IMpurity E](/CAS/20210111/GIF/1402150-34-8.gif) |
Ticagrelor IMpurity E |
1402150-34-8 |
C26H30F2N6O5S |
![Benzenebutanoicacid,b-[[(1,1-diMethylethoxy)carbonyl]aMino]-2,4,5-trifluoro-,Methylester,(bR)-](/CAS/20150408/GIF/881995-73-9.gif) |
Benzenebutanoicacid,b-[[(1,1-diMethylethoxy)carbonyl]aMino]-2,4,5-trifluoro-,Methylester,(bR)- |
881995-73-9 |
C16H20F3NO4 |
![4-[(2,4-ジクロロ-5-メトキシフェニル)アミノ]-7-ヒドロキシ-6-メトキシ-3-キノリンカルボニトリル](/CAS/20200611/GIF/1460227-29-5.gif) |
4-[(2,4-ジクロロ-5-メトキシフェニル)アミノ]-7-ヒドロキシ-6-メトキシ-3-キノリンカルボニトリル |
1460227-29-5 |
C18H13Cl2N3O3 |
![Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate)](/CAS/20150408/GIF/1447715-44-7.gif) |
Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate) |
1447715-44-7 |
C18H31NO4 |
![Dabigatran iMpurity F](/CAS/20211123/GIF/1642853-67-5.gif) |
Dabigatran iMpurity F |
1642853-67-5 |
C19H20N4O4 |
![Decitabine iMpurity 4](/CAS/20180713/GIF/863396-35-4.gif) |
Decitabine iMpurity 4 |
863396-35-4 |
C6H12O4 |
![Gliclazide iMpurity D](/CAS/20200515/GIF/1136426-19-1.gif) |
Gliclazide iMpurity D |
1136426-19-1 |
C15H20N2O3S |
![Losartan IMpurity C (Isolosartan)](/CAS/20150408/GIF/114799-13-2.gif) |
Losartan IMpurity C (Isolosartan) |
114799-13-2 |
C22H23ClN6O |
![Posaconazole DiastereoisoMer interMediate 2](/CAS/20180808/GIF/166583-12-6.gif) |
Posaconazole DiastereoisoMer interMediate 2 |
166583-12-6 |
C21H21F2N3O4S |
![Quetiapine IMpurity P (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine fuMarate))](/CAS/20150408/GIF/1011758-03-4.gif) |
Quetiapine IMpurity P (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine fuMarate)) |
1011758-03-4 |
C19H21N3S |
![TaMsulosin IMpurity B](/CAS/20150408/GIF/CB02707239.gif) |
TaMsulosin IMpurity B |
|
C20H28N2O5S |
![Ticagrelor iMpurity N](/) |
Ticagrelor iMpurity N |
|
|
![Tirofiban IMpurity (4,4'-Dipyridyl-1,5-Pentane)](/CAS/20200515/GIF/25382-33-6.gif) |
Tirofiban IMpurity (4,4'-Dipyridyl-1,5-Pentane) |
25382-33-6 |
C15H18N2 |
![3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]-](/CAS/20150408/GIF/492444-39-0.gif) |
3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]- |
492444-39-0 |
C19H23ClN4O2 |
![Vardenafil Oxopiperazine (IMpurity)](/CAS/20200611/GIF/448184-58-5.gif) |
Vardenafil Oxopiperazine (IMpurity) |
448184-58-5 |
C21H26N6O5S |
![IverMectin B1 Aglycon](/CAS/20180808/GIF/73162-95-5.gif) |
IverMectin B1 Aglycon |
73162-95-5 |
C34H50O8 |
![9α-BroMobudesonide](/CAS/20180808/GIF/313474-59-8.gif) |
9α-BroMobudesonide |
313474-59-8 |
C25H33BrO6 |
![N-(5-Chloro-2-pyridinyl)-2-pyrazinecarboxaMide (Zopiclone IMpurity)](/CAS/20150408/GIF/349125-10-6.gif) |
N-(5-Chloro-2-pyridinyl)-2-pyrazinecarboxaMide (Zopiclone IMpurity) |
349125-10-6 |
C10H7ClN4O |
![2-Methyl SiMvastatin (Mixture Of DiasteroisoMers)](/CAS/20210111/GIF/774611-54-0.gif) |
2-Methyl SiMvastatin (Mixture Of DiasteroisoMers) |
774611-54-0 |
C26H40O5 |
![(7R)-3-メチル-7-(ホルミルアミノ)セファム-3-エン-4-カルボン酸](/CAS/20200611/GIF/184696-69-3.gif) |
(7R)-3-メチル-7-(ホルミルアミノ)セファム-3-エン-4-カルボン酸 |
184696-69-3 |
C8H8N2O3S |
![5,6-ジメトキシ-2-[(4-ピペリジル)メチル]インダン塩酸塩(DONEPEZIL IMPURITY)](/CAS/20150408/GIF/1034439-43-4.gif) |
5,6-ジメトキシ-2-[(4-ピペリジル)メチル]インダン塩酸塩(DONEPEZIL IMPURITY) |
1034439-43-4 |
C17H26ClNO2 |
![CarfilzoMib IMpurity](/CAS/20211123/GIF/1541171-65-6.gif) |
CarfilzoMib IMpurity |
1541171-65-6 |
C41H61N5O10S |
![BendaMustine IMpurity](/) |
BendaMustine IMpurity |
|
|
![D-Alanine, N-[[P(S),2'R]-2'-cyano-2'-deoxy-2'-Methyl-P-phenyl-5'-cytidylyl]-, 1-Methylethyl ester](/CAS/20180808/GIF/1496552-28-3.gif) |
D-Alanine, N-[[P(S),2'R]-2'-cyano-2'-deoxy-2'-Methyl-P-phenyl-5'-cytidylyl]-, 1-Methylethyl ester |
1496552-28-3 |
C22H29FN3O9P |
![D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)-](/CAS/20180906/GIF/842133-16-8.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)- |
842133-16-8 |
C24H26O5S |
![(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile](/CAS/20150408/GIF/1150310-15-8.gif) |
(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile |
1150310-15-8 |
C15H15N3O5 |
![(E)-N,N-ジエチル-2-シアノ-3-(3-エトキシ-4-ヒドロキシ-5-ニトロフェニル)アクリルアミド](/CAS/20150408/GIF/857629-79-9.gif) |
(E)-N,N-ジエチル-2-シアノ-3-(3-エトキシ-4-ヒドロキシ-5-ニトロフェニル)アクリルアミド |
857629-79-9 |
C16H19N3O5 |
![(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate](/CAS/20150408/GIF/149709-59-1.gif) |
(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate |
149709-59-1 |
C25H31NO4 |
![1-(3-アミノプロピル)-4-(2-メトキシフェニル)ピペラジン](/CAS/20150408/GIF/20529-23-1.gif) |
1-(3-アミノプロピル)-4-(2-メトキシフェニル)ピペラジン |
20529-23-1 |
C14H23N3O |
![(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/404874-94-8.gif) |
(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
404874-94-8 |
C20H20FNO4 |
![(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/CB02735623.gif) |
(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one |
|
C20H21NO4 |
![Posaconazole iMpurity 4](/CAS/20200611/GIF/2125944-53-6.gif) |
Posaconazole iMpurity 4 |
2125944-53-6 |
C30H35N5O3 |
![Everolimus Ring-Opening Impurity](/CAS/20180808/GIF/1708118-13-1.gif) |
Everolimus Ring-Opening Impurity |
1708118-13-1 |
C53H83NO14 |
![Topiroxostat Impurity 6](/CAS/20200611/GIF/2044704-63-2.gif) |
Topiroxostat Impurity 6 |
2044704-63-2 |
C7H8N4O2 |
![Dienogest Impurity I](/CAS/20211123/GIF/65928-65-6.gif) |
Dienogest Impurity I |
65928-65-6 |
C20H27NO2 |
![Febuxostat Impurity 8](/CAS/20180808/GIF/144060-62-8.gif) |
Febuxostat Impurity 8 |
144060-62-8 |
C16H17NO4S |
![Lornoxicam Impurity 9](/CAS/20200611/GIF/70374-36-6.gif) |
Lornoxicam Impurity 9 |
70374-36-6 |
C6H6ClNO4S2 |
![Ticagrelor Related Compound 3](/CAS/20200611/GIF/88756-83-6.gif) |
Ticagrelor Related Compound 3 |
88756-83-6 |
C8H15NO3 |
![Tadalafil EP Impurity](/CAS/20180808/GIF/479545-76-1.gif) |
Tadalafil EP Impurity |
479545-76-1 |
C21H16N2O5 |
![Vonoprazan Impurity C](/) |
Vonoprazan Impurity C |
|
|
![(5RS)-5-Ethyl-2,6-diimino-5-phenyl-1,2,5,6-tetrahydropyrimidin-4(3H)-one](/CAS/20180629/GIF/69125-70-8.gif) |
(5RS)-5-Ethyl-2,6-diimino-5-phenyl-1,2,5,6-tetrahydropyrimidin-4(3H)-one |
69125-70-8 |
C12H14N4O |
![(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180629/GIF/1012341-54-6.gif) |
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-54-6 |
C23H29NO4 |
![3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide](/CAS/20180629/GIF/917391-28-7.gif) |
3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide |
917391-28-7 |
C12H10F3N3O |
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl-](/CAS/20180629/GIF/132810-75-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl- |
132810-75-4 |
C23H31N3 |
![(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one](/CAS/20180629/GIF/1839099-22-7.gif) |
(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one |
1839099-22-7 |
C25H26N6O2 |
![Linagliptin Impurity L](/) |
Linagliptin Impurity L |
|
|
![Linagliptin Impurity S](/CAS/20180808/GIF/668273-74-3.gif) |
Linagliptin Impurity S |
668273-74-3 |
C30H36N8O4 |
![(R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile](/CAS/20180629/GIF/CB03042203.gif) |
(R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
|
C17H18FN5O2 |
![Posaconazole Impurity 10](/) |
Posaconazole Impurity 10 |
|
|
![Posaconazole Impurity 63](/CAS/20210111/GIF/208187-15-9.gif) |
Posaconazole Impurity 63 |
208187-15-9 |
C20H26F2O4 |
![(S)-4,5,6,7-Tetrahydro-N2,N6-propionyl-2,6-benzothiazolediaMine](/CAS/20200611/GIF/1373869-91-0.gif) |
(S)-4,5,6,7-Tetrahydro-N2,N6-propionyl-2,6-benzothiazolediaMine |
1373869-91-0 |
C11H17N3O2 |
![SofosBuvir impurity 62](/) |
SofosBuvir impurity 62 |
|
|
![Tamoxifen EP Impurity E](/CAS/20180703/GIF/CB83360132.gif) |
Tamoxifen EP Impurity E |
|
C26H29NO |
![Tenofovir impurity P](/) |
Tenofovir impurity P |
|
|
![Tirofiban Impurity 3](/CAS/20200515/GIF/1346918-32-8.gif) |
Tirofiban Impurity 3 |
1346918-32-8 |
C13H19NO5S |
![Trelagliptin Impurity 19](/) |
Trelagliptin Impurity 19 |
|
|
![N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide](/CAS/20180601/GIF/2028267-73-2.gif) |
N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide |
2028267-73-2 |
C16H20N6O2 |
![D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-, (1S)-](/CAS/20211123/GIF/333359-90-3.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-, (1S)- |
333359-90-3 |
C20H23ClO6 |
![Flucloxacillin Sodium Impurity E](/) |
Flucloxacillin Sodium Impurity E |
|
|
![Amifostine Impurity 1](/) |
Amifostine Impurity 1 |
|
|
![Clindamycin Phosphate EP Impurity H](/) |
Clindamycin Phosphate EP Impurity H |
|
|
![2-Thia-5-azabicyclo[2.2.1]heptane-5-carboxylic acid, 3-oxo-, (4-nitrophenyl)methyl ester, (1S,4S)-](/CAS/20200611/GIF/151072-00-3.gif) |
2-Thia-5-azabicyclo[2.2.1]heptane-5-carboxylic acid, 3-oxo-, (4-nitrophenyl)methyl ester, (1S,4S)- |
151072-00-3 |
C13H12N2O5S |
![Brexpiprazole Impurity](/CAS/20200611/GIF/2116542-21-1.gif) |
Brexpiprazole Impurity |
2116542-21-1 |
C38H40N4O4S |
![4-(1-(2,3-dimethylphenyl)propyl)-1H-imidazole](/CAS/20180601/GIF/86347-62-8.gif) |
4-(1-(2,3-dimethylphenyl)propyl)-1H-imidazole |
86347-62-8 |
C14H18N2 |
![Atomoxetine EP Impurity A](/CAS/20210111/GIF/873310-33-9.gif) |
Atomoxetine EP Impurity A |
873310-33-9 |
C16H20ClNO |
![Famciclovir Impurity 12](/CAS/20180906/GIF/122497-20-5.gif) |
Famciclovir Impurity 12 |
122497-20-5 |
C12H15N5O4 |
![Levofloxacin Impurity 22](/CAS/20180601/GIF/177472-29-6.gif) |
Levofloxacin Impurity 22 |
177472-29-6 |
C20H25F2N3O4 |
![Methylprednisolone EP Impurity E](/CAS/20180601/GIF/229019-44-7.gif) |
Methylprednisolone EP Impurity E |
229019-44-7 |
C21H28O4 |
![Pantoprazole Impurity 1](/CAS/20210111/GIF/812664-93-0.gif) |
Pantoprazole Impurity 1 |
812664-93-0 |
C16H14ClF2N3O4S |
![Ticagrelor Related Compound 38D-Tartrate](/CAS/20200611/GIF/2165881-71-8.gif) |
Ticagrelor Related Compound 38D-Tartrate |
2165881-71-8 |
C10H19NO4 |
![1-(1-BENZOTHIOPHEN-7-YL)PIPERAZINE](/CAS/20180601/GIF/105685-06-1.gif) |
1-(1-BENZOTHIOPHEN-7-YL)PIPERAZINE |
105685-06-1 |
C12H14N2S |
![4-methyl-N-(2-methyl-5-nitrophenyl)-6-(pyridin-3-yl)pyrimidin-2-amine](/CAS/20180703/GIF/CB83382314.gif) |
4-methyl-N-(2-methyl-5-nitrophenyl)-6-(pyridin-3-yl)pyrimidin-2-amine |
|
C17H15N5O2 |
![Parecoxib Impurity 12](/CAS/20200611/GIF/2229657-81-0.gif) |
Parecoxib Impurity 12 |
2229657-81-0 |
C19H18N2O4S |
![Bortezomib Impurity W](/) |
Bortezomib Impurity W |
|
|
![Butyphthalide impurity 43](/CAS/20200611/GIF/952412-99-6.gif) |
Butyphthalide impurity 43 |
952412-99-6 |
C11H14O3 |